OBJECTIVES: Reports on adverse neurological events following transcatheter aortic valve implantation (TAVI) have focused on strokes, while more subtle postoperative cognitive decline has not yet been systematically investigated. In this study, we prospectively examined neurological and cognitive outcomes in patients undergoing transapical (TA) and surgical aortic valve replacement (AVR). METHODS: A total of 64 patients with severe symptomatic aortic stenosis were investigated between January 2008 and July 2009. Clinical neurological examination and comprehensive neuropsychological testing were performed before and after the procedure, at discharge and at 3-month follow-up. Diffusion-weighted magnetic resonance imaging (DW-MRI) was applied to detect morphological brain injury. RESULTS: TA-TAVI patients (n = 27) were older and at higher surgical risk compared with surgical AVR patients (n = 37; mean age 82.2 ± 4.7 vs 67.5 ± 8.9 years; log EuroSCORE 36.4 ± 13.2 vs 2.6 ± 8.5%, both P <0.001). There was one stroke in each group (3.7 vs 2.7%, P = 0.49), both classified as embolic based on imaging characteristics. After TA-TAVI, cognitive tests showed no decline during follow-up, while, after AVR, 7 of 11 tests showed a decline early after surgery. Similarly, with-in patient analysis showed that the rate of individuals with clinically relevant cognitive decline was increased early after AVR (TA-TAVI vs AVR: 18 vs 46% at discharge [P = 0.03]; 28 vs 6% at 3 months [P = 0.04]). New focal ischaemic cerebral lesions were detected on DW-MRI in 58% (7 of 12) of patients after TA-TAVI vs 34% (12 of 35) after AVR (P = 0.13). The number of brain lesions per patient and cumulative embolic load per patient were similar between groups. An association between postoperative cerebral ischaemia and cognitive dysfunction was not found (odds ratio 2.37, 95% confidence interval 0.05-113.75, P = 0.66). CONCLUSIONS: Cognitive function was only mildly impaired after TA-TAVI when compared with a marked, albeit transient, decline after surgical AVR. Focal embolic brain injury tended to occur more frequently after TA-TAVI, but this was not related to cognitive decline during the 3-month follow-up.
OBJECTIVES: Reports on adverse neurological events following transcatheter aortic valve implantation (TAVI) have focused on strokes, while more subtle postoperative cognitive decline has not yet been systematically investigated. In this study, we prospectively examined neurological and cognitive outcomes in patients undergoing transapical (TA) and surgical aortic valve replacement (AVR). METHODS: A total of 64 patients with severe symptomatic aortic stenosis were investigated between January 2008 and July 2009. Clinical neurological examination and comprehensive neuropsychological testing were performed before and after the procedure, at discharge and at 3-month follow-up. Diffusion-weighted magnetic resonance imaging (DW-MRI) was applied to detect morphological brain injury. RESULTS: TA-TAVI patients (n = 27) were older and at higher surgical risk compared with surgical AVR patients (n = 37; mean age 82.2 ± 4.7 vs 67.5 ± 8.9 years; log EuroSCORE 36.4 ± 13.2 vs 2.6 ± 8.5%, both P <0.001). There was one stroke in each group (3.7 vs 2.7%, P = 0.49), both classified as embolic based on imaging characteristics. After TA-TAVI, cognitive tests showed no decline during follow-up, while, after AVR, 7 of 11 tests showed a decline early after surgery. Similarly, with-in patient analysis showed that the rate of individuals with clinically relevant cognitive decline was increased early after AVR (TA-TAVI vs AVR: 18 vs 46% at discharge [P = 0.03]; 28 vs 6% at 3 months [P = 0.04]). New focal ischaemic cerebral lesions were detected on DW-MRI in 58% (7 of 12) of patients after TA-TAVI vs 34% (12 of 35) after AVR (P = 0.13). The number of brain lesions per patient and cumulative embolic load per patient were similar between groups. An association between postoperative cerebral ischaemia and cognitive dysfunction was not found (odds ratio 2.37, 95% confidence interval 0.05-113.75, P = 0.66). CONCLUSIONS: Cognitive function was only mildly impaired after TA-TAVI when compared with a marked, albeit transient, decline after surgical AVR. Focal embolic brain injury tended to occur more frequently after TA-TAVI, but this was not related to cognitive decline during the 3-month follow-up.
Authors: Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock Journal: N Engl J Med Date: 2010-09-22 Impact factor: 91.245
Authors: Josep Rodés-Cabau; Eric Dumont; Robert H Boone; Eric Larose; Rodrigo Bagur; Ronen Gurvitch; Fernand Bédard; Daniel Doyle; Robert De Larochellière; Cleonie Jayasuria; Jacques Villeneuve; Alier Marrero; Mélanie Côté; Philippe Pibarot; John G Webb Journal: J Am Coll Cardiol Date: 2011-01-04 Impact factor: 24.094
Authors: Mark F Newman; Joseph P Mathew; Hilary P Grocott; G Burkhard Mackensen; Terri Monk; Kathleen A Welsh-Bohmer; James A Blumenthal; Daniel T Laskowitz; Daniel B Mark Journal: Lancet Date: 2006-08-19 Impact factor: 79.321
Authors: Thomas Walther; Paul Simon; Todd Dewey; Gerhard Wimmer-Greinecker; Volkmar Falk; Marie T Kasimir; Mirko Doss; Michael A Borger; Gerhard Schuler; Dietmar Glogar; Wolfgang Fehske; Ernst Wolner; Friedrich W Mohr; Michael Mack Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Thomas F Floyd; Pallav N Shah; Catherine C Price; Francis Harris; Sarah J Ratcliffe; Michael A Acker; Joseph E Bavaria; Hind Rahmouni; Bettina Kuersten; Susan Wiegers; Michael L McGarvey; Joseph Y Woo; Alberto A Pochettino; Elias R Melhem Journal: Ann Thorac Surg Date: 2006-06 Impact factor: 4.330
Authors: Alexander Ghanem; Andreas Müller; Claas P Nähle; Justine Kocurek; Nikos Werner; Christoph Hammerstingl; Hans H Schild; Jörg O Schwab; Fritz Mellert; Rolf Fimmers; Georg Nickenig; Daniel Thomas Journal: J Am Coll Cardiol Date: 2010-02-24 Impact factor: 24.094
Authors: Philipp Kahlert; Stephan C Knipp; Marc Schlamann; Matthias Thielmann; Fadi Al-Rashid; Marcel Weber; Uwe Johansson; Daniel Wendt; Heinz G Jakob; Michael Forsting; Stefan Sack; Raimund Erbel; Holger Eggebrecht Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: Martin Arnold; Susanne Schulz-Heise; Stephan Achenbach; Sabine Ott; Arnd Dörfler; Dieter Ropers; Richard Feyrer; Friedrich Einhaus; Sabrina Loders; Faidi Mahmoud; Olaf Roerick; Werner G Daniel; Michael Weyand; Stephan M Ensminger; Josef Ludwig Journal: JACC Cardiovasc Interv Date: 2010-11 Impact factor: 11.195
Authors: Mariam Samim; Jeroen Hendrikse; H Bart van der Worp; Pierfrancesco Agostoni; Freek Nijhoff; Pieter A Doevendans; Pieter R Stella Journal: Clin Res Cardiol Date: 2015-01-18 Impact factor: 5.460
Authors: Stephanie M Meller; Andreas Baumbach; Szilard Voros; Michael Mullen; Alexandra J Lansky Journal: BMC Med Date: 2013-12-11 Impact factor: 8.775
Authors: Giovanni Pulignano; Michele Massimo Gulizia; Samuele Baldasseroni; Francesco Bedogni; Giovanni Cioffi; Ciro Indolfi; Francesco Romeo; Adriano Murrone; Francesco Musumeci; Alessandro Parolari; Leonardo Patanè; Paolo Giuseppe Pino; Annalisa Mongiardo; Carmen Spaccarotella; Roberto Di Bartolomeo; Giuseppe Musumeci Journal: Eur Heart J Suppl Date: 2017-05-02 Impact factor: 1.803
Authors: Erica S Ghezzi; Tyler J Ross; Daniel Davis; Peter J Psaltis; Tobias Loetscher; Hannah A D Keage Journal: Am J Cardiol Date: 2020-04-28 Impact factor: 2.778
Authors: Tarique Al Musa; Akhlaque Uddin; Catherine Loveday; Laura E Dobson; Mark Igra; Fiona Richards; Peter P Swoboda; Anvesha Singh; Pankaj Garg; James R J Foley; Graham J Fent; Anthony J P Goddard; Christopher Malkin; Sven Plein; Daniel J Blackman; Gerald P McCann; John P Greenwood Journal: BMJ Open Date: 2019-01-21 Impact factor: 2.692